Quản lý chảy máu cho các phẫu thuật mở hộp sọ và phẫu thuật chỉnh hình mặt ở trẻ em

10.1016/j.anclin.2012.05.001

10.1111/j.1460-9592.2008.02713.x

10.1097/SCS.0b013e31819b9429

GoobieSM ProctorMR MearaJGet al.Can we predict which infants have more adverse events post craniofacial surgery?15th Congress of the International Society of Craniofacial Surgery; Jackson Hole Wyoming2013.

10.1213/ANE.0000000000000080

10.1097/00000539-200110000-00017

10.1007/s00701-009-0409-z

Tsuda H, 1988, Tissue‐type plasminogen activator in patients with intracranial meningiomas, Thromb Haemost, 60, 508, 10.1055/s-0038-1647001

10.3109/02688699409101183

Edgington TS, 1980, Activation of the coagulation system in association with neoplasia, J Lab Clin Med, 96, 1

10.1159/000337245

10.1097/ALN.0b013e3181f22b5a

10.1093/bja/aei052

10.1213/ANE.0b013e31822e1853

10.1111/j.1460-9592.2009.03227.x

10.1097/00005373-199705000-00016

10.1213/01.ane.0000268712.00756.dd

10.1111/j.1365-2141.2008.07022.x

10.1111/j.1460-9592.2010.03470.x

Society of Pediatric Anesthesia.Hyperkalemia statement www.pedsanesthesia.org 2011. Available at:www.wakeupsafe.org/hyperkalemia_statement.pdf. Accessed 15 January 2014.

10.1111/trf.12192

World Health Organization.Sixty‐third World Health Assembly WHA63/2010/REC/1 Resolutions and decisions 2010.2010. Available at:http://apps.who.int/gb/ebwha/pdf_files/WHA63-REC1/WHA63_REC1-en.pdf. Accessed 15 January 2014.

The American Medical Association.Proceedings from the National Summit On Overuse 2012. Available at:www.ama-assn.org/resourses/doc/cqi/overuse-proceedings-paper.pdf. Accessed 15 January 2014.

World Health Organization2014. Available at:www.who.int/medical_devices/initiatives/anaemia_control/en/. Accessed 15 January 2014.

10.1111/trf.12328

10.1097/PRS.0b013e3182589dbf

10.1046/j.1460-9592.2003.01091.x

10.1213/ANE.0b013e318273f4ae

10.1111/j.1365-3148.2006.00716.x

10.1046/j.1537-2995.2002.00132.x

10.1111/pan.12093

10.1213/ane.0b013e31817340ad

10.1111/aas.12131

10.1016/j.tmrv.2013.08.004

10.1111/pan.12341

10.1097/01.PRS.0000110324.31791.5C

10.1093/bja/85.4.550

10.1111/j.0041-1132.2004.04176.x

10.1213/ANE.0b013e318293d81e

10.1213/ANE.0b013e31828a73f1

10.1213/ANE.0b013e31827175da

Perel P, 2011, Colloids versus crystalloids for fluid resuscitation in critically ill patients, Cochrane Database Syst Rev, CD000567

10.1056/NEJMoa040232

10.1213/ANE.0b013e3181b6b3b5

10.1016/S0003-4975(01)02745-X

10.1097/00003246-200106000-00038

10.1111/j.1365-2044.2007.05186.x

Perel P, 2007, Colloids versus crystalloids for fluid resuscitation in critically ill patients, Cochrane Database Syst Rev, CD000567

10.1111/j.1460-9592.2010.03476.x

Hildebrandt B, 2007, Intraoperative fresh‐frozen plasma versus human albumin in craniofacial surgery–a pilot study comparing coagulation profiles in infants younger than 12 months, Thromb Haemost, 98, 172, 10.1160/TH06-08-0475

10.1111/j.1365-2141.2004.04973.x

10.1016/j.jpeds.2011.08.013

10.1097/00000542-200607000-00030

10.1097/EJA.0b013e32835f4d5b

The Canadian Medical Association Expert Working Group, 1997, Guidelines for red blood cell and plasma transfusion for adults and children, Can Med Assoc J, 156, S1

10.1111/j.1365-2141.2006.06355.x

10.1056/NEJMoa066240

10.1136/adc.2007.135731

10.1097/00045391-200209000-00006

10.1182/asheducation-2003.1.575

10.1097/01.ta.0000250497.08101.8b

10.1097/TA.0b013e3181271ba3

10.1097/TA.0b013e318160ba2f

10.1111/j.1537-2995.2010.02632.x

10.1016/j.bpa.2009.09.009

10.1111/pan.12116

10.1093/bja/aer342

10.1093/bja/aeq258

10.1213/00000539-199704000-00008

10.1186/cc8943

10.1111/j.1537-2995.2010.02752.x

10.1111/j.1365-2141.2004.04815.x

10.1213/ane.0b013e318163fb26

10.1177/1076029612458149

10.1186/cc10488

10.1097/MBC.0b013e32832da1c5

FDA.Human Fibrinogen Concentrate Pasteurized (Riastap) Indication: For the treatment of congenital fibrinogen deficiency. Available at:http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/UCM162780.pdf. Accessed 15 January 2014.

RiaSTAP™Distribution www.blood.ca. Customer Letter # 2013‐04. Available at:http://www.bloodservices.ca/CentreApps/Internet/UW_V502_MainEngine.nsf/resources/CustomerLetters2013/$file/CL2013-04.pdf. Accessed 15 January 2014.

10.1111/j.1460-9592.2011.03709.x

10.1111/pan.12193

Goerlinger K, 2011, First‐line therapy with coagulation factor concentrates combined with point‐of‐care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single‐center cohort study, Anesthesiology, 115, 1179, 10.1097/ALN.0b013e31823497dd

10.1186/1757-7241-20-15

Simpson E, 2012, Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia, Cochrane Database Syst Rev, CD005011

Goobie SM, 2013, The case for the use of tranexamic acid, Pediatr Anesth, 23, 281

10.1097/ALN.0b013e318210fd8f

10.1097/ALN.0b013e318210f9e3

10.1007/s40262-013-0033-1

10.1093/bja/aes507

10.1097/SCS.0b013e3182a2e23f

Pharmacia and Upjohn Co DoP, 2008, Cyklokapron Drug Description

Xanodyne Pharmaceuticals I, 2005, Amicar Package Insert

10.1097/00043426-199502000-00009

10.1016/j.ejcts.2008.09.038

10.1213/ANE.0b013e3181c92b23

10.1016/j.athoracsur.2011.07.085

10.1172/JCI63375

10.1111/pan.12279

10.3171/jns.2003.99.2.0287

10.1111/pan.12312

10.1007/s00701-011-1179-y

10.1227/NEU.0b013e31821ff91b

10.1186/1745-6215-14-143

10.1186/1745-6215-13-87